Vellabio

Vellabio sells microbiome-focused skincare and ingestible supplements built around post-biotic actives. The line spans cleansers, serums, creams and daily sachet powders priced USD $28-$78, placing it in the accessible-premium tier. Distribution is DTC through vellabio.com with limited-batch drops; no brick-and-mortar stockists are listed. The brand formulates with Lactobacillus ferment lysate screened for skin-barrier repair peptides, then freeze-dries it into powders that remain active without refrigeration. Every SKU is pH-optimized to 4.5-5.5 and third-party tested for microbial identity; batch-level Certificates of Analysis are posted online. Their “Post-Biotic Recovery Cream” and “Microbiome Balance Powder” routinely sell out within days of restock. Core buyers are 25-45-year-old professionals who track gut-skin axis research, track cycles in health-tracking apps and prefer science-backed “bio-aligned” routines over botanical clean beauty. They value transparency (full genome sequencing data), minimal ingredient lists and recyclable mono-material packaging. Vellabio competes with both clinical dermaceutical brands and ingestible wellness startups by bridging topicals and supplements under one microbiome platform. Where rivals market probiotics that may degrade, Vellabio uses heat-killed, shelf-stable post-biotics, positioning them as faster-acting and safer for immunocompromised users.